Advanced Search


Study ID Status Title Patient Level Data
114824 Completed Tumour markers study in gastric cancer for cancer Immunotherapy (NOT FINAL TITLE)
114825 Completed Long term immunogenicity and safety of GSK Biologicals’ Herpes Zoster vaccine 1437173A in healthy subjects
114837 Terminated A 16-week, Phase 2a, single-arm, multi-center, open-label study to evaluate the safety and efficacy of GSK1278863 after switching from recombinant human erythropoietin (rhEPO), in hemodialysis-dependent subjects with anemia associated with chronic kidney disease who are chronically hyporesponsive to rhEPO Study Listed on
114840 Terminated A randomized, single blind, placebo-controlled, single ascending dose/repeat dose cohort study to assess safety, tolerability, pharmacokinetics and immunogenicity of GSK1223249 in patients with relapsing forms of multiple sclerosis. Study Listed on
114843 Completed Safety and immunogenicity of a booster dose of new formulations of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (GSK217744)
114849 Completed Dermal Safety Study of GSK2585823 (Clindamycin 1%-Benzoyl peroxide 3% gel) with Healthy Japanese Male and Female Subjects Study Listed on
114855 Terminated A randomised, double-blind, placebo-controlled, parallel-group, multicentre study to determine the efficacy and safety of 2 doses of retigabine immediate release (900 mg/day and 600 mg/day) used as adjunctive therapy in adult Asian subjects with drug-resistant partial-onset seizures. Study Listed on
114856 Completed A multidose study in subjects with type 2 diabetes mellitus to assess the pharmacokinetics and pharmacodynamics of albiglutide Study Listed on
114858 Completed Immunogenicity and safety study of GSK Biologicals' meningococcal conjugate vaccine (GSK 134612) when co-administered with routine vaccines in healthy infants and toddlers
114866 Completed Incidence, Prevalence, and Symptom Burden associated with Advanced Renal Cell Carcinoma in commercially insured population (Pharmetrics)
114867 Completed Incidence, Prevalence, and Symptom Burden associated with Advanced Renal Cell Carcinoma in commercially insured population (IHCIS)
114872 Completed An observational study to assess the burden of drug-resistant partial epilepsy in Italy
114876 Completed An exploratory study to assess two doses of GSK2402968 in the treatment of ambulant boys with Duchenne muscular dystrophy (DMD)
114877 Active, Not Recruiting Drug Use Investigation for REVOLADE (Chronic Idiopathic Thrombocytopenic Purpura)
114880 Completed Special Drug Use Investigation for Botox® (botulinum) Spasticity
114883 Completed An open-label, fixed sequence study to evaluate pharmacokinetics, safety and tolerability of single and repeated dose of extended-release bupropion hydrochloride (bupropion XL) tablets 150 mg and 300 mg once daily in Chinese healthy volunteers
114885 Completed A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Subjects
114886 Terminated Safety and immunogenicity study of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 when administered to adults with TB disease
114910 Completed A study on the impact of rotavirus vaccination on hospitalisations for rotavirus gastroenteritis in children aged <5 years in Australia
114915 Completed A Phase IIIb, randomized, open-label study of the safety and efficacy of GSK1349572 (dolutegravir, DTG) 50 mg once daily compared to darunavir/ritonavir (DRV/r) 800 mg/100 mg once daily each administered with fixed-dose dual nucleoside reverse transcriptase inhibitor therapy over 96 weeks in HIV-1 infected antiretroviral naïve adult subjects
114917 Completed Assessment of safety of GlaxoSmithKline (GSK) Biologicals’ combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine, Infanrix-IPV when administered according to the approved Prescribing Information in Korea
114919 Completed An open-label, randomised, crossover study to assess the relative bioavailability of different 2mg formulations of GSK2018682(S1P1 agonist) in healthy volunteers Study Listed on
114922 Completed A randomized cross-over study to evaluate the pharmacokinetics and pharmacodynamics of twice daily oral administration of GSK1325756, compared to placebo, in healthy subjects; and the pharmacokinetic profile of twice daily oral administration of GSK1325756 in healthy fed and fasted elderly subjects Study Listed on
114926 Completed An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects
114930 Completed DB2114930: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.